394 related articles for article (PubMed ID: 18653982)
21. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
[TBL] [Abstract][Full Text] [Related]
22. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals.
Kim O; Kim SS; Park MS; Suh SD; Lee MW; Kim KS; Yoon JD; Lee JS
Int J STD AIDS; 2003 Jan; 14(1):46-9. PubMed ID: 12590793
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia.
Tiruneh M
Ethiop Med J; 2008 Oct; 46(4):359-66. PubMed ID: 19271400
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
Bagga PK; Singh SP
Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
[TBL] [Abstract][Full Text] [Related]
26. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope.
Ismail AM; Ziada HN; Sheashaa HA; Shehab El-Din AB
Eur J Intern Med; 2009 Sep; 20(5):490-3. PubMed ID: 19712851
[TBL] [Abstract][Full Text] [Related]
27. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
Mutlu B; Meriç M; Willke A
Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
[TBL] [Abstract][Full Text] [Related]
28. Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004.
Tanaka J; Mizui M; Nagakami H; Katayama K; Tabuchi A; Komiya Y; Miyakawa Y; Yoshizawa H
Intervirology; 2008; 51(1):33-41. PubMed ID: 18309247
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of hepatitis B and C in Egypt and Africa.
Attia MA
Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of anti HCV antibodies among blood donors in Kathmandu valley, Nepal.
Karki S; Ghimire P; Tiwari BR; Rajkarnikar M
Kathmandu Univ Med J (KUMJ); 2008; 6(24):491-6. PubMed ID: 19483431
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria].
Ayed Z; Houinato D; Hocine M; Ranger-Rogez S; Denis F
Bull Soc Pathol Exot; 1995 Apr; 88(5):225-8. PubMed ID: 8646011
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.
Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME; Goral V
Intervirology; 2007; 50(2):133-7. PubMed ID: 17191015
[TBL] [Abstract][Full Text] [Related]
33. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
Gavilán Carrasco JC; González Santos P; Rosario Díaz E
Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
Pirillo MF; Bassani L; Germinario EA; Mancini MG; Vyankandondera J; Okong P; Vella S; Giuliano M
J Med Virol; 2007 Dec; 79(12):1797-801. PubMed ID: 17935164
[TBL] [Abstract][Full Text] [Related]
36. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana.
Arora D; Arora B; Khetarpal A
Indian J Pathol Microbiol; 2010; 53(2):308-9. PubMed ID: 20551540
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks.
Demirtürk N; Demirdal T; Toprak D; Altindiş M; Aktepe OC
Turk J Gastroenterol; 2006 Dec; 17(4):267-72. PubMed ID: 17205404
[TBL] [Abstract][Full Text] [Related]
39. Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
Hundie GB; Raj VS; GebreMichael D; Haagmans BL
J Med Virol; 2017 Jul; 89(7):1300-1303. PubMed ID: 28121005
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of hepatitis viruses and risk factors in blood donors of Veracruz, Mexico.
Lopez-Balderas N; Bravo E; Camara M; Hernandez-Romano P
J Infect Dev Ctries; 2015 Mar; 9(3):274-82. PubMed ID: 25771465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
